Page last updated: 2024-08-25

cromakalim and 5-carboxamidotryptamine

cromakalim has been researched along with 5-carboxamidotryptamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choe, E; Ferrara, J; Flint, L; Franklin, E; Grivas, T; Hyman, A; Lippton, H	1

Other Studies

1 other study(ies) available for cromakalim and 5-carboxamidotryptamine

Article	Year
Femoral vasodilation to cromakalim is blocked by U37883A, a non-sulphonylurea that selectively inhibits KATP channels. The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:3 Topics: Adamantane; Analysis of Variance; Animals; Benzopyrans; Cromakalim; Dogs; Drug Interactions; Femur; Injections, Intravenous; Isoproterenol; Morpholines; Nitroglycerin; Potassium Channels; Pyrroles; Regional Blood Flow; Serotonin; Serotonin Receptor Agonists; Vasodilation; Vasodilator Agents	1995

Article

Year

Femoral vasodilation to cromakalim is blocked by U37883A, a non-sulphonylurea that selectively inhibits KATP channels.

The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:3

Topics: Adamantane; Analysis of Variance; Animals; Benzopyrans; Cromakalim; Dogs; Drug Interactions; Femur; Injections, Intravenous; Isoproterenol; Morpholines; Nitroglycerin; Potassium Channels; Pyrroles; Regional Blood Flow; Serotonin; Serotonin Receptor Agonists; Vasodilation; Vasodilator Agents

1995